Dose‐dense adjuvant chemotherapy in HER2‐positive early breast cancer patients before and after the introduction of trastuzumab: Exploratory analysis of the GIM2 trial
2019 ◽
Vol 147
(1)
◽
pp. 160-169
◽
Keyword(s):
2018 ◽
Vol 36
(15_suppl)
◽
pp. e12573-e12573
Keyword(s):
2006 ◽
Vol 17
(3)
◽
pp. 280-282
Keyword(s):
2005 ◽
Vol 97
(23)
◽
pp. 1724-1733
◽
Keyword(s):
Keyword(s):